Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003051091 | SCV003448622 | uncertain significance | Xeroderma pigmentosum, group F; Cockayne syndrome; Fanconi anemia complementation group Q | 2022-08-12 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with ERCC4-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is present in population databases (rs780318166, gnomAD 0.01%). This sequence change disrupts the translational stop signal of the ERCC4 mRNA. It is expected to extend the length of the ERCC4 protein by 83 additional amino acid residues. |